We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

EIS Crowdfunding Opportunities


Premium businessagent.com 2018 EIS
Business Agent* is an FCA approved aggregation and rating portal for equity and debt crowdfunding investments. AIM is shrinking, legacy stock markets are too expensive to maintain and do not serve the requirements of SMEs, banks are closing branches, lending less and are paying little or no interest to investors. As a result of this there is a huge growth in equity crowdfunding and P2P lending which has seen the launch of hundreds of alternative lenders & platforms that has created a new c.£3bn marketplace, expanding at 66% p.a. There is no single portal or trusted ratings index for investors to compare on a like for like basis and no secondary market to facilitate exits.   * NextFin is the new trading name of Business Agent Ltd The solution NextFin aggregates equity and debt crowdfunding investments to create the alternative finance marketplace. This makes it easy for investors and lenders to find and compare opportunities by presenting all investment offerings in one place. With the addition of a free of charge ratings service investors will be able to view ratings of every equity crowdfunding pitch, every P2P site, and every equity crowdfunding site. NextFin’s technology will constantly track these companies and investments providing the investor real-time intelligence on which to base investment decisions. The platforms and entrepreneurs will be self promoting and marketing their ratings driving thousands of visitors a month to the NextFin site, in the same way businesses refer their potential clients to Trip Advisor and Trustpilot. There is an estimated 10 million website/platform visitors per month across the whole of the alternative finance market. NextFin is targeting to direct 5% of this highly profiled traffic to its platform from which it will earn between £5-£8 per click from advertisers and partners. In addition an in-house brokerage service also earns between 1%-6% commissions on loan placements. A future revenue stream (not featured in the financials) will be developed once visitor traffic reaches critical mass. This will see Nextfin being able to realise the full value of its captured ratings data and visitor traffic by launching a secondary market, which is estimated to be a £5bn marketplace. NextFin is raising £500k at a pre-money valuation of £800k to: • Acquire CrowdRating for a non cash consideration of 20% equity• Develop P2P and Equity site ratings• Expand the management, infrastructure and marketing resource• Increase visitor traffic to 6m a year via rating referrals Owing to the size of the market and rapid growth of the industry, enterprise valuations in alternative finance are based on visitor traffic, market share and registered users. Recent published valuations of companies with visitor traffic of over 6m per year are in excess of £70m. NextFin is the market leading aggregator and has first mover advantage. It has the potential to exceed these valuations because it is the whole of market aggregator and is currently the only ratings service provider as it grows to achieve 500,000 visitors p.m.
investment: £382,391 target: £249,772
status: Active 6 days
to go
More Information
153%
Arca is helping to build the market for property market risk transfer by dealing in derivatives for domestic and commercial properties. Nick Ruddell has held senior roles for the last 30 years with banks and big interdealer brokers.
investment: £676,500 target: £1,500,000 pre-money valuation: £6,000,000
status: Funded
More Information
45%
Cloud-based SaaS software with the purpose of efficiently generating corporate management reports to reduce operational costs and improve data quality. Synapse's service can be implemented into pre-existing financial reporting systems to produce automated reports, even in large companies. Customers include Lloyds Bank, who have signed a 2-year term and the Bank of England have contacted Synapse to potentially integrate the system.
investment: £807,759 target: £900,010
status: Active
More Information
90%
Probe Technology EIS
Probe has developed microeye to change the way doctors take blood samples. Microeye provides a continous sample from venus blood without removing whole blood. When coupled with Probe’s continumon it gives the clinician continous data showing trends and rate of change.
investment: £233,630 target: £499,968 pre-money valuation: £5,049,066
status: Funded
More Information
47%
ADC Biotechnology Limited Technology EIS
ADC Biotechnology provides specialist drug manufacturing services based on its own patented Lock-Release™ processing technology, focused on a new wave of oncology therapeutics called antibody-drug conjugates (“ADCs”) being developed by pharmaceutical companies worldwide.
investment: £6,243,502 target: £6,000,000 pre-money valuation: £60,666,667
status: Extended
More Information
104%
 AskIf is platform that provides loan funding to small businesses. Each borrower has one or more relationship managers they can talk to. They are collecting data around social impact and are planning on monetising the data within their own business model and also to external stakeholders. AskIf will use the funding to expand referral partnership, increase the amount of their lending partners that are using the platform, make strong relationships to bring in new tech resource in house and bring in loan capital. 
investment: £668,753 target: £399,995 pre-money valuation: £3,001,323
status: Extended
More Information
167%
A wind turbine's generator currently uses rare-earth magnets which cost £40 per kg, Greenspur have developed innovative generators which use ferrite magnets, an abundantly available material, that cost as little as £1 per kg. The company have made further advancements by removing the gearbox, which has resulted in lower maintenance costs and improved efficiency.
investment: £368,640 target: £500,000 pre-money valuation: £2,340,909
status: Active
More Information
74%
Driftrock are a digitasl media media marketing company who specialise in creating simple easy to use advertising tools.
investment: £800,278 target: £600,002 pre-money valuation: £5,702,540
status: Stretch
More Information
133%
CELLMED Medical EIS
Cellmed is an immuno-oncology company that are developing treatments for ovarian cancer.  Their lead product PROCURE a dendritic cell vaccine and they are now looking to expand the treatment to target solid tumors.    
investment: £520,294 target: £500,000 pre-money valuation: £2,400,232
status: Stretch
More Information
104%
Redag Crop Protection Limited Catering, Food and Drink EIS
Redag Crop is an agrochemical discovery business focused on products that play a vital role in controlling the pests and diseases that threaten our global food supply. The growing population, expected to grow by 8 billion by 2020 and then 9 billion by 2050, will need more crops than the existing land can produce. Each hectare will need to produce 2.5 times as many crops as they do now. 
investment: £1,250,000 target: £1,250,000 pre-money valuation: £12,638,889
status: Extended
More Information
100%
Obby have created a platform that helps independent teachers generate an income doing by giving them access people about crafts using curated, high quality, courses.
investment: £663,543 target: £749,980 pre-money valuation: £3,999,735
status: Funded
More Information
88%
KiteEdge's Apex Technology EIS
Kite edge has created a cognitive search service which has been built to specifically meet the needs of asset managers. Individuals can search and set up feeds that draw insight from their specific work (email, news, investment research, internal documents)
investment: £433,000 target: £600,000 pre-money valuation: £2,694,893
status: Funded
More Information
72%
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph